Standard Operating Procedure for Post-Approval Change Impact Assessment
| Department | Regulatory Affairs |
| SOP No. | RA/2026/664 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 10/04/2026 |
| Effective Date | 10/04/2026 |
| Review Date | 10/04/2028 |
Purpose
This SOP defines a standardized and systematic approach for evaluating the impact of any post-approval changes on regulatory submissions, product quality, safety, efficacy, and compliance status. It ensures timely and compliant management of variations, maintaining regulatory alignment and product lifecycle integrity, while minimizing risk and enabling documented control throughout the change management process.
Scope
This SOP applies to all post-approval changes involving product formulation, manufacturing processes, equipment, testing methods, packaging, labeling, and regulatory documentation within the Regulatory Affairs department. It covers assessment activities for all types of pharmaceutical dosage forms and related lifecycle maintenance. Changes solely related to internal administrative updates without regulatory impact are excluded from this procedure.
Responsibilities
- Regulatory Affairs Specialist: Execute impact assessments, prepare documentation, and communicate findings.
- Quality Assurance: Provide oversight and review impact assessment outputs for compliance and quality considerations.
- Product Development/Manufacturing: Supply technical data and support risk evaluation of changes.
- Regulatory Affairs Manager: Review, approve, and oversee coordination of post-approval change submissions.
- Quality Control/Laboratory: Validate testing requirement changes if applicable.
- Document Control: Maintain version control and archival of impact assessment reports and related records.
Accountability
The Regulatory Affairs Manager holds overall accountability for the implementation, compliance, periodic review, escalation, and effectiveness of this SOP within the department. The manager ensures continuous training, resource availability, and adherence to regulatory requirements related to post-approval change impact assessment activities.
Procedure
1. Initiation and Change Identification: Upon identification of a proposed post-approval change, the Regulatory Affairs Specialist logs the change request and collects all relevant change documentation, including technical, manufacturing, and regulatory data.
2. Preliminary Review: Conduct a preliminary review to determine the nature and scope of the change. Categorize the change by type (e.g., formulation, process, equipment) and assess potential regulatory impact.
3. Data Gathering and Analysis: Collaborate with cross-functional teams (Manufacturing, QA, QC, Product Development) to gather detailed information regarding the change, including batch data, validation reports, stability data, and any previous approvals.
4. Risk Assessment: Perform a comprehensive risk assessment evaluating potential impact on product quality, safety, efficacy, compliance status, and regulatory filings. Use established risk assessment tools and criteria aligned with GMP and regulatory guidelines.
5. Impact Documentation: Document findings within a formal Post-Approval Change Impact Assessment Report. Describe the change, provide technical rationale, assess regulatory classification (e.g., minor, moderate, major), and recommend regulatory submission strategy and timelines.
6. Review and Approval: Submit the impact assessment report for review to Quality Assurance and Regulatory Affairs Manager. Address any feedback or queries and obtain formal approval before proceeding with change implementation or submission preparation.
7. Regulatory Submission Preparation: Based on the approved impact assessment, compile necessary regulatory submission dossiers or variation applications, ensuring compliance with local and international requirements.
8. Record Keeping and Documentation Control: Ensure all documentation including assessment reports, approvals, correspondences, and final submission records are maintained in controlled repositories according to document control policies and retention timelines.
9. Training and Communication: Inform and train relevant personnel on the change and updated procedures post-approval to ensure smooth implementation and compliance adherence.
10. Monitoring and Review: Monitor the implementation post-change for any deviations or quality issues. Engage in periodic review of the SOP for continual improvement based on feedback, regulatory changes, and audit findings.
Abbreviations
- GMP – Good Manufacturing Practice
- QA – Quality Assurance
- QC – Quality Control
- RA – Regulatory Affairs
- SOP – Standard Operating Procedure
- CAPA – Corrective and Preventive Action
- MAH – Marketing Authorization Holder
Documents
- Post-Approval Change Impact Assessment Report (Annexure-1)
- Risk Assessment Template for Post-Approval Changes (Annexure-2)
- Change Request Form (Annexure-3)
References
- ICH Q12 – Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
- EU Guidelines on Variations to Marketing Authorisations
- FDA Guidance for Industry: Changes to an Approved NDA or ANDA
- Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) GMP Guide
- Internal Quality Manual and Document Control Procedures
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Post-Approval Change Impact Assessment Report
| Title | Post-Approval Change Impact Assessment Report |
| Purpose | To document technical and regulatory evaluation of a proposed post-approval change and determine impact and submission requirements. |
Fields:
- Change Request ID: CR-2026-045
- Date of Assessment: 12/04/2026
- Change Type: Manufacturing Process Modification
- Description of Change: Modification of granulation endpoint to improve blend uniformity.
- Regulatory Impact Category: Moderate
- Risk Assessment Summary: No impact on product safety or efficacy anticipated.
- Recommended Submission Type: Prior Approval Variation
- Approvals:
- Assessed By: Regulatory Affairs Specialist
- Reviewed By: Quality Assurance
- Approved By: Regulatory Affairs Manager
- Date of Approval: 15/04/2026
- Remarks: All data supporting change included; submission dossier preparation ongoing.
Annexure-2: Risk Assessment Template for Post-Approval Changes
| Title | Risk Assessment Template for Post-Approval Changes |
| Purpose | To evaluate potential risks associated with a post-approval change and determine mitigation measures. |
Fields:
- Change Request ID: CR-2026-045
- Date: 12/04/2026
- Change Description: Modification of granulation endpoint.
- Risk Parameters Assessed:
- Product Quality: Low Risk
- Patient Safety: Negligible Risk
- Regulatory Compliance: Medium Risk
- Manufacturing Efficiency: Positive Impact
- Risk Mitigation Measures: Enhanced in-process monitoring.
- Overall Risk Level: Low to Moderate
- Assessed By: Regulatory Affairs Specialist
- Review Date: 15/04/2026
Annexure-3: Change Request Form
| Title | Change Request Form |
| Purpose | To formally request a post-approval change and initiate the impact assessment process. |
Fields:
- Request ID: CR-2026-045
- Date Submitted: 10/04/2026
- Requested By: Manufacturing Department
- Change Type: Process Change
- Description: Adjust granulation endpoint to optimize blend uniformity.
- Reason for Change: Improve product consistency and reduce batch failures.
- Supporting Documents Attached: Validation Report, Stability Data Summary
- Submission to Regulatory Affairs: 10/04/2026
- Preliminary Assessment Status: Pending
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 10/04/2026 | 1.0 | Initial issue | New SOP creation |